JPRN-UMIN000030472招募中未知
Validation of predictive and prognostic markers in upper gastrointestinal cancer - Validation of predictive and prognostic markers
Shimane University Faculty of Medicine0 个研究点目标入组 800 人开始时间: 2017年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma, and multicentric cancer. 2.Patients with severe complication (intestinal paralysis, intestinal obstruction, interstitial pneumonitis, pulmonary fibrosis, severe diabetes, heart failure, renal failure, liver cirrhosis, liver failure, etc.). 3.Patients with infections.
研究者
相似试验
已完成
不适用
Clinical evaluation of prognostic indicators using vital signs in critically ill patientsCritically ill patientsJPRN-UMIN000048711Tokyo Women's Medical University1,238
招募中
Unknown
Clinical evaluation of prognostic indicators using vital signs in critically ill patientsJPRN-UMIN000050855St. Marianna University School of Medicine1,000
招募中
不适用
Identifying and validating predictive and prognostic biomarkers in male Germ Cell Tumours to improve the management and outcomes in both stage 1 and disseminated disease.Testicular cancerGerm Cell Tumour (GCT)Cancer - TesticularSeminomaACTRN12618000931279Walter and Eliza Hall Institute for Medical Research800
尚未招募
不适用
Biomarkers in Pancreatic CancerHistologically or cytologically confirmed pancreatic cancerCancer - PancreaticACTRN12616000519459The Walter and Eliza Hall Institute of Medical Research500
已完成
不适用
Validation study of the prognostic and predictive value of TP53 signature for breast cancer Collateral researchBreast cancerJPRN-UMIN000042055Japan Agency for Medical Research and Development107